Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2003
03/26/2003EP1294685A1 Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/26/2003EP1294679A1 Beta-amino acid nitrile derivatives
03/26/2003EP1294646A2 Devices and method for production of traceable immunizing drinking water, other liquids and gas
03/26/2003EP1294409A2 Membrane-permeant peptide complexes for medical imaging
03/26/2003EP1294399A2 Methods and composition for oral vaccination
03/26/2003EP1294398A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294397A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294393A2 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment and diagnosis of athersclerosis
03/26/2003EP1294391A2 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion
03/26/2003EP1294378A2 Thrombopoietin mimetics
03/26/2003EP0998477B1 Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents
03/26/2003EP0930310B1 Isocoumarin derivatives and use thereof in drugs
03/26/2003EP0863757B1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use
03/26/2003EP0625159B1 Ikaros: a regulatory gene involved in t-cell differentiation
03/26/2003CN1406230A 2,4-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
03/26/2003CN1406229A Pyrimidine compounds
03/26/2003CN1406225A Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
03/26/2003CN1405314A Cryptoporus volvatus fermented product, and its preparation method and application
03/26/2003CN1404833A 药物组合物 The pharmaceutical composition of
03/26/2003CN1103760C 1,3-dihydro-2H-imidazol-2-one derivatives having PDEIV and cytokinin inhibiting activity
03/26/2003CN1103593C Synergistic composition
03/25/2003US6538149 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo [1,2-g]chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
03/25/2003US6538123 Vaccine composition for preventing or treating hepatitis C
03/25/2003US6538121 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
03/25/2003US6538110 Monoclonal antibodies against the interleukin 2 receptor
03/25/2003US6538035 And treatment of Chronic Obstructive Pulmonary Disease and allergic rhinitis
03/25/2003US6538009 Pyrazole derivatives as anti-inflammatory/analgesic agents
03/25/2003US6537984 Contacting a targeted solid tumor cell population with a combination of a vinca alkaloid selected from vinblastine, vincristine, vinorelbine, and a triptolide in combination dosage to reduce the targeted tumor cell population
03/25/2003US6537980 Vitamin D analogues and their pharmaceutical use
03/25/2003US6537812 Methods for the production of TcRγδ+ T cells
03/25/2003US6537768 Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC panca antigens
03/25/2003US6537764 Method of identifying inhibitors of C—C chemokine receptor 3
03/25/2003US6537763 Nucleotide sequences coding binding protein for use used in controling immune response and screening for modulators of receptor activity
03/25/2003US6537594 Vaccina virus comprising cytokine and/or tumor associated antigen genes
03/25/2003US6537587 Compositions containing muscle-derived active agents
03/25/2003US6537573 Combination dosage form comprising cetirizine and pseudoephedrine
03/25/2003US6537560 Nucleic acid sequences encoding melanoma antigens recognized by T lymphocytes and protein and peptides encoded by these sequences
03/25/2003US6537559 Staphylococcus aureus antigen-containing whole cell vaccine
03/25/2003US6537555 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
03/25/2003US6537519 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases
03/21/2003WO2002026702A1 Phenoxyphenyl alkane sulfonates
03/21/2003CA2423171A1 Phenoxyphenyl alkane sulfonates
03/20/2003WO2003023042A1 Recombinant mva capable of expressing structural hcv antigens
03/20/2003WO2003023026A1 Alphavirus replicon vector systems
03/20/2003WO2003023018A2 A method for isolating, culturing and differentiating intestinal stem cells for therapeutic use
03/20/2003WO2003023014A2 Human ion channels
03/20/2003WO2003023008A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003023001A2 Novel proteins and nucleic acids encoding same
03/20/2003WO2003022994A2 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
03/20/2003WO2003022886A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
03/20/2003WO2003022883A2 Use of proteins for the production of a medicament for stimulating the innate non specific immune system
03/20/2003WO2003022877A1 Crystal structure of baff, and use thereof in drug design
03/20/2003WO2003022871A2 Peptides having a c- terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i
03/20/2003WO2003022867A2 Peptides derived from the superantigen (sag) env protein of herv-k18 and their use in obtaining sag-inhibitory antibodies and in vaccination against sag
03/20/2003WO2003022852A2 Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
03/20/2003WO2003022842A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
03/20/2003WO2003022828A1 Use of n-acyl homoserine lactones for the treatment of insulitis
03/20/2003WO2003022814A1 Indole derivatives
03/20/2003WO2003022813A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient
03/20/2003WO2003022801A1 Reverse hydroxamic acid derivatives
03/20/2003WO2003022360A2 Thermotherapy via targeted delivery of nanoscale magnetic particles
03/20/2003WO2003022324A1 Medical devices containing rapamycin analogs
03/20/2003WO2003022309A1 Remedies for allergic diseases
03/20/2003WO2003022298A2 Use of a protein of the crmp family for treating diseases related to the immune system
03/20/2003WO2003022296A1 Method and composition for treating immune complex associated disorders
03/20/2003WO2003022291A1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
03/20/2003WO2003022277A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
03/20/2003WO2003022271A1 Lymphocytic activation inhibitor and remedial agent for autoimmune disease
03/20/2003WO2003022257A1 External preparations for the skin
03/20/2003WO2003022255A2 Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy
03/20/2003WO2003022253A1 Dosage forms having prolonged active ingredient release
03/20/2003WO2003022216A2 Biaryl substituted purine derivatives as potent antiproliferative agents
03/20/2003WO2003022215A2 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response
03/20/2003WO2003022123A2 Methods of kidney transplantation utilizing developing nephric tissue
03/20/2003WO2003002117A3 Niaciamide and derivatives in combination with aminosugar
03/20/2003WO2003000195A3 Method and material for treating immune diseases
03/20/2003WO2002102344A3 No-synthase inhibitor and use thereof
03/20/2003WO2002100845A8 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/20/2003WO2002098363A3 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM
03/20/2003WO2002096366A3 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
03/20/2003WO2002092792A3 Antigen-dependent reduction of specific immune responses by influencing co-stimulation
03/20/2003WO2002092131A3 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins
03/20/2003WO2002087424A3 Treatment and diagnosis of macrophage mediated disease
03/20/2003WO2002060373A3 Indole derivatives and their uses as heparanase inhibitors
03/20/2003WO2002053733A3 Regulation of human b7-h2 protein
03/20/2003WO2002053171A3 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity
03/20/2003WO2002050255A3 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof
03/20/2003WO2002046189A3 Aryl ether substituted imidazoquinolines
03/20/2003WO2002028408A3 Compositions and methods for the transport of biologically active agents across cellular barriers
03/20/2003WO2002022809A9 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
03/20/2003WO2002020736A3 Proteases
03/20/2003WO2002018445A9 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
03/20/2003WO2002004520A3 Transporters and ion channels
03/20/2003WO2002004490A3 Lipid metabolism molecules
03/20/2003WO2001090153A3 Reagents for cell selection and methods of use
03/20/2003WO2001073104A9 Beta-glucans from filamentous fungi
03/20/2003WO2001070253A8 Use of mia in immunotherapy
03/20/2003US20030056229 Nucleotide sequences coding polypeptide for use in the treatment of leukemias, autoimmune and arthritic diseases
03/20/2003US20030055286 Il-8 receptor antagonists
03/20/2003US20030055260 Il-8 receptor antagonists
1 ... 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 ... 1172